Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted four newly-hired employees inducement options to purchase an aggregate of 18,000 shares of KalVista common stock on October 3, 2022 as inducements material to each employee entering into employment with KalVista. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

The options have an exercise price of $14.24 per share, which was equal to the closing price of KalVista common stock on the grant date. One-fourth of the options vest on the one-year anniversary of the vesting commencement date and the remainder vest in equal monthly installments over the next three years, in each case subject to the new employee's continued service with the company. Each stock option has a 10-year term and is subject to the terms and conditions of KalVista's Inducement Equity Incentive Plan and a stock option agreement covering the grant.

About KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need. KalVista has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially targeting hereditary angioedema (HAE) and diabetic macular edema (DME). KalVista is developing sebetralstat as an oral on-demand therapy for HAE attacks and is enrolling the Phase 3 KONFIDENT clinical trial. In addition, KalVista's oral Factor XIIa inhibitor program represents a new generation of therapies that may further improve treatment for people living with HAE. In DME, an intravitreally administered plasma kallikrein inhibitor, called KVD001, has completed a Phase 2 clinical trial.

For more information, please visit www.kalvista.com.


These press releases may also interest you

at 02:05
Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud, today announced the deployment of its cloud-native Packet Gateway (PGW) to PM Factory B.V. in the Netherlands. PM Factory can...

at 02:05
Today, most banking services are not adapted for people with disabilities. 90% of visually impaired people have once in their life faced fraud or encountered a mistake at a point of sales. This statistic prompted Thales to develop a solution which...

at 02:05
Regulatory News: Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL) has selected Thales Alenia Space (Thales 67 % and Leonardo 33 %) to build a next-generation highly flexible, software-defined satellite (SDS). The Flexsat (for flexible...

at 02:00
nCino, Inc. , a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that Hamburg Commercial Bank (HCOB) is now live on the nCino Bank Operating System®. nCino is supporting the...

at 02:00
As part of its mission to inspire people to keep a clear head and have the confidence to be their best selves in the face of life's greatest challenges, Clear has teamed up with global football content and media business, Footballco, and Mindshare to...

at 02:00
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced that, together with Finland's Euformatics and Hungary's Oncompass Medicine, the BCP-led partnership has now successfully been awarded contract for the...



News published on 5 october 2022 at 07:05 and distributed by: